ID: ALA3978562

Max Phase: Preclinical

Molecular Formula: C32H36N5O6P

Molecular Weight: 617.64

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCOP(=O)(O)c1ccc2cc1CN(C)C(=O)[C@H](Nc1ccc3c(N)nccc3c1)c1ccc(c(C)c1)[C@@H](C)COC(=O)N2

Standard InChI:  InChI=1S/C32H36N5O6P/c1-5-43-44(40,41)28-11-8-25-16-23(28)17-37(4)31(38)29(35-24-7-10-27-21(15-24)12-13-34-30(27)33)22-6-9-26(19(2)14-22)20(3)18-42-32(39)36-25/h6-16,20,29,35H,5,17-18H2,1-4H3,(H2,33,34)(H,36,39)(H,40,41)/t20-,29+/m0/s1

Standard InChI Key:  RCTSRSYRSFZKIR-AFJIDDCJSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 617.64

Molecular Weight (Monoisotopic): 617.2403

AlogP: 5.45

#Rotatable Bonds: 5

Polar Surface Area: 156.11

Molecular Species: ZWITTERION

HBA: 8

HBD: 4

#RO5 Violations: 2

HBA (Lipinski): 11

HBD (Lipinski): 5

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 2.02

CX Basic pKa: 9.17

CX LogP: 1.57

CX LogD: 1.59

Aromatic Rings: 4

Heavy Atoms: 44

QED Weighted: 0.21

Np Likeness Score: 0.26

References

1. Zhang X, Glunz PW, Johnson JA, Jiang W, Jacutin-Porte S, Ladziata V, Zou Y, Phillips MS, Wurtz NR, Parkhurst B, Rendina AR, Harper TM, Cheney DL, Luettgen JM, Wong PC, Seiffert D, Wexler RR, Priestley ES..  (2016)  Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor Complex.,  59  (15): [PMID:27455395] [10.1021/acs.jmedchem.6b00469]

Source

Source(1):

• Scientific Literature